Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The screenshots show no substantive updates to the study record beyond minor formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-27T21:01:00.000Z thumbnail image
  3. Check
    35 days ago
    Change Detected
    Summary
    Adds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T07:59:10.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a new page revision tag (v3.1.0) and removed several MedlinePlus topics, simplifying the topic scope. No core content or time-sensitive information appears updated.
    Difference
    0.4%
    Check dated 2025-09-29T04:37:39.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T22:22:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:33:34.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing several previous location entries. Notably, the facility name and specific locations in the United States, Europe, and Asia have been emphasized.
    Difference
    11%
    Check dated 2025-08-31T12:28:31.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.